Low dose [qnco]
Oral [spco]
Combination [qlco]
17 beta-Estradiol [horm, phsu, strd]
Norethisterone [horm, phsu, strd]
Acetate [orch, phsu]
postmenopausal [tmco]
Women [popg]
Decrease [qlco]
Factor VII [aapp, bacs, phsu]
Fibrinogen [aapp, bacs, phsu]
Antithrombin [aapp, phsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Objective [inpr]
controversies [socb]
Concern [idcn]
Hormone replacement therapy [topp]
effects [qlco]
Blood coagulation [ortf]
Fibrinolysis [phsf]
Study [mnob]
carried [acty]
Out [spco]
Evaluate [ftcn]
effects [qlco]
Administered [ftcn]
Low dose [qnco]
17beta estradiol [horm, phsu, strd]
Norethisterone acetate [horm, phsu, strd]
Coagulation [ortf]
fibrinolytic [topp]
Methods [inpr]
Conduct [inbe]
randomized [resa]
Double-Blind Study [resa]
placebo-controlled [resa]
Health [idcn]
postmenopausal [tmco]
Women [popg]
Group [idcn]
placebo [topp]
Group [idcn]
N NOS [aapp, imft]
Group [idcn]
Receive [qlco]
Oral [spco]
Continuous [idcn]
Combined [qlco]
mg% [qnco]
Norethisterone acetate [horm, phsu, strd]
mg% [qnco]
N NOS [aapp, imft]
Group [idcn]
Receive [qlco]
Oral [spco]
Continuous [idcn]
Combined [qlco]
mg% [qnco]
norethindrone acetate 0.5 MG [clnd]
N NOS [aapp, imft]
Low dose [qnco]
Norethisterone acetate [horm, phsu, strd]
Induced [ftcn]
Plasma [bdsu]
Factor VII [aapp, bacs, phsu]
Fibrinogen [aapp, bacs, phsu]
Antithrombin [aapp, phsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
Compared [acty]
placebo [topp]
treatment [ftcn]
Conclusions [idcn]
Low dose [qnco]
mg% [qnco]
Combination [qlco]
Norethisterone acetate [horm, phsu, strd]
Favorable [qlco]
Factor VII Activity [lbpr]
Fibrinogen [aapp, bacs, phsu]
Compared [acty]
placebo [topp]
Plasma [bdsu]
Plasminogen Activator Inhibitor 1 [aapp, bacs]
???lead [elii, hops]
increased activity [fndg]
fibrinolytic [topp]
findings [ftcn]
Suggest [idcn]
Decreased [qnco]
coronary heart disease [dsyn]
Antithrombin Activity [lbpr]
Reduced [qlco]
Venous Thromboembolism [patf]
Clinical Significance [fndg]
Levels [qlco]
Clarified [acty]
